MétaCan
Menu
Back to cohort
Record W4395034442 · doi:10.1055/s-0044-1782054

Improved Skeletal Dynamics in Adults Treated With Palopegteriparatide for Hypoparathyroidism: 52-Week Analysis of Phase 3 PaTHway Trial

2024· article· en· W4395034442 on OpenAlexaff
Elena Tsourdi, Aliya Khan, Mishaela R. Rubin, Dolores Shoback, Schwarz Peter, Lynn Kohlmeier, Andrea Palermo, B.L. Clarke, Erik Fink Eriksen, Filomena Cetani, Rajesh Kumar Jain, Carol Zhao, Bryant Lai, Jenny Ukena, Christopher T. Sibley, Michael S. Ominsky, Aimee D Shu, Lars Rejnmark

Bibliographic record

VenueOsteologie/Osteology · 2024
Typearticle
Languageen
FieldMedicine
TopicThyroid and Parathyroid Surgery
Canadian institutionsMcMaster University
Fundersnot available
KeywordsHypoparathyroidismMedicineEndocrinology

Abstract

fetched live from OpenAlex

Introduction: Evaluate the temporal changes in and relationship between skeletal endpoints in response to palopegteriparatide (TransCon PTH), a prodrug with sustained release of PTH(1-34), in individuals with chronic hypoparathyroidism. Methods: PaTHway is a phase 3 trial of TransCon PTH with a randomized, placebo-controlled 26-week blinded period and 156-week open-label extension. Serum bone turnover markers (BTM) of bone formation (procollagen type 1 N-terminal propeptide [P1NP]) and bone resorption (C-telopeptide [CTx]) were assessed at baseline and weeks 12, 26, 38, and 52. Bone mineral density (BMD) was assessed by DXA at the lumbar spine, total hip, and distal 1/3 radius at baseline, weeks 26 and 52. Skeletal endpoints are reported herein for participants randomized to TransCon PTH with week 52 data (n=59). Results: At baseline, participants in the TransCon PTH group had a mean (SD) age of 49 (13) years; 75% were female, 41% of whom were postmenopausal. Through week 52, 81% (48/59) maintained normal serum calcium (8.3-10.6 mg/dL) and independence from conventional therapy (≤600 mg/day of elemental calcium and no active vitamin D). TransCon PTH treatment initially increased CTx and P1NP; responses peaked by week 12 and 26, respectively, and then declined through week 52 (Figure). From weeks 26 to 52, BTM decreased most in those with the highest values at week 26. Mean baseline BMD was high, as expected in hypoparathyroidism. With exposure to TransCon PTH over 52 weeks, mean BMD Z-scores and T-scores declined from above 0 toward age- and/or sex-matched norms at the lumbar spine and total hip, with a smaller magnitude of change from week 26 to 52 (Figure). Changes in BMD at the spine and hip were consistent across age, sex, and postmenopausal status, and at week 26 were inversely correlated with changes in P1NP and CTx at week 12 (R: -0.23 to -0.48). Discussion: TransCon PTH treatment resulted in mobilization of calcium from the low bone turnover state in adults with hypoparathyroidism. Increases in BTM were correlated with declines from disease-elevated BMD at baseline. After week 26, BTM normalized toward sex and menopausal status appropriate levels and corresponded to lesser declines in BMD through week 52, similar to the results through week 110 in the Phase 2 PaTH Forward trial. These 52-week results reflect temporal changes trending toward a new skeletal steady state closer to age-appropriate norms with continued use of TransCon PTH in hypoparathyroidism.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.296
Teacher spread0.275 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueOsteologie/OsteologySame topicThyroid and Parathyroid SurgeryFrench-language works237,207